We recently had the chance to attend the annual Wells Fargo Healthcare Conference held in Boston. It is a great event with management teams from over 100 publicly traded healthcare companies making presentations to an audience of analysts, investors, and portfolio managers. These presenting companies run the gamut from small biotechnology firms to health analytics companies to household names like Johnson & Johnson and Medtronic. We go into this conference each year with the three goals: to get a progress report on the names currently in our portfolio; to find some new potential candidates on which to focus our future research; and to learn something new about the industry.